CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03015363
NCT03015363N/ACompleted
CompareCT.gov

Comparison, Calibration, and Validation of the Non-invasive Cloud DX Pulsewave Health MonitorTM With Direct Invasive Radial and Central Arterial Measurements During Cardiac Catheterization

Cardiovascular Research New Brunswick·observational·Posted Jan 10, 2017·Updated Aug 30, 2021

In Brief

An observational study for Hypertension. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The objective of the Cloud DX Pulsewave Health Monitor study is to prospectively calibrate and validate a novel, non-invasive wrist cuff blood pressure device against the gold standard for hemodynamic monitoring (intra-arterial pressure) in voluntarily consented patient participants who are scheduled for an elective cardiac catheterization procedure for clinically valid reasons.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesCanada
CollaboratorsHorizon Health Network, Dalhousie University, Cloud DX Inc., New Brunswick Health Research Foundation

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 10, 2017
Enrollment StartNov 1, 2013
Primary CompletionMay 1, 2016
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 9.5 years ago